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Abstract
NF-kB plays a vital role in cellular immune and inflammatory response, survival, and proliferation by regulating the
transcription of various genes involved in these processes. To activate transcription, RelA (a prominent NF-kB family
member) interacts with transcriptional co-activators like CREB-binding protein (CBP) and its paralog p300 in addition to its
cognate kB sites on the promoter/enhancer regions of DNA. The RelA:CBP/p300 complex is comprised of two
components—first, DNA binding domain of RelA interacts with the KIX domain of CBP/p300, and second, the transcriptional
activation domain (TAD) of RelA binds to the TAZ1 domain of CBP/p300. A phosphorylation event of a well-conserved
RelA(Ser276) is prerequisite for the former interaction to occur and is considered a decisive factor for the overall RelA:CBP/
p300 interaction. The role of the latter interaction in the transcription of RelA-activated genes remains unclear. Here we
provide the solution structure of the latter component of the RelA:CBP complex by NMR spectroscopy. The structure reveals
the folding of RelA–TA2 (a section of TAD) upon binding to TAZ1 through its well-conserved hydrophobic sites in a series of
grooves on the TAZ1 surface. The structural analysis coupled with the mechanistic studies by mutational and isothermal
calorimetric analyses allowed the design of RelA-mutants that selectively abrogated the two distinct components of the
RelA:CBP/p300 interaction. Detailed studies of these RelA mutants using cell-based techniques, mathematical modeling, and
genome-wide gene expression analysis showed that a major set of the RelA-activated genes, larger than previously
believed, is affected by this interaction. We further show how the RelA:CBP/p300 interaction controls the nuclear response
of NF-kB through the negative feedback loop of NF-kB pathway. Additionally, chromatin analyses of RelA target gene
promoters showed constitutive recruitment of CBP/p300, thus indicating a possible role of CBP/p300 in recruitment of RelA
to its target promoter sites.
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Introduction
The NF-kB family of inducible transcription factors has
emerged as a major player in immune response [1], activating a
plethora of immunoregulatory genes upon stimulation. In
vertebrates, the family is comprised of five members, namely,
RelA (also known as p65), RelB, c-Rel, p50, and p52. They exist in
various combinations of homo- and hetero-dimers, with RelA:p50
being the most abundant NF-kB dimer present in the cell. All of
the family members share a structurally conserved N-terminal rel
homology region (RHR), which is responsible for DNA binding
and also contains the dimerization domain (DD). RelA, RelB, and
c-Rel distinguish themselves from p50 and p52 by possessing the
transcriptional activation domain (TAD), which is vital for the
transcriptional regulation of the NF-kB-regulated genes. In
unstimulated cells, NF-kB is maintained in a latent state in the
cytoplasm by the family of Inhibitor-kB (IkB) proteins, which
strongly bind to the RHR domain of NF-kB dimers, thereby
masking its nuclear localization signal. Upon stimulation, a
cascade of signaling events led to the degradation of the IkB
proteins, thus releasing the NF-kB dimers, which then enter the
nucleus to regulate the transcription of NF-kB-dependent genes.
In the nucleus, NF-kB activates transcription by binding to its
cognate kB sites in the promoters/enhancers of its target genes
[2,3]. However, mere binding of the NF-kB to its cognate kB sites
does not ensure transcriptional initiation, and further requires the
assembly of the ‘‘basal transcription machinery’’ on the transcrip-
tion start site. Assembly of the transcription initiation complex
requires NF-kB to interact with the mediator complex, various
transcriptional adaptors, and co-activator proteins like CREB-
binding protein (CBP) and its paralog p300 [4–7]. CBP/p300 are
general transcriptional co-activators that help NF-kB bridge with
the basal transcription machinery [8]. CBP/p300 interact with a
large array of transcription factors to integrate multiple cellular
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signaling pathways [9,10] and also possess chromatin-remodeling
capabilities owing to their histone- and transcription factor–
acetylating properties.
To date, it is widely believed that in the nucleus NF-kB
recruits CBP/p300 to its target promoter sites, and in this
process it must compete with various other cellular transcription
factors for the limiting amounts of CBP/p300 [11]. However, in
recent genome-wide analyses of gene promoters/enhancers
using ChIP-chip and ChIP-seq technology, p300 has emerged
as a prominent marker for enhancers [12]. p300 is also pre-
loaded in most of the promoters and enhancers of NF-kB-
regulated genes marked with histone-H3 lysine 4 trimethyl
(H3K4me3) and histone H3 lysine 4 monomethyl (H3K4me1),
respectively, in unstimulated THP-1 and HeLa cells [13]. In
light of these new findings, the question arises that if p300 is
already preloaded on the promoter/enhancer regions of the NF-
kB target genes, then what is the role of NF-kB:CBP/p300
binding in the NF-kB activated transcription.
Among the NF-kB proteins, RelA is the most potent,
ubiquitously expressed and well-studied family member. It
contains a TAD, which can be further divided into two regions,
TA1 and TA2, as depicted in Figure 1A [14]. Although the
activation of the NF-kB pathway is extensively studied [15],
mechanistic details of the transcription initiation process by NF-kB
at the promoter site are limited [16]. This can partly be attributed
to the lack of any structural information and limited overall
knowledge of RelA–TAD [17,18]. The interaction of RelA with
CBP/p300 represents a key step in the initiation of transcription of
a subset of RelA-activated genes [19]. RelA interacts with CBP/
p300 in a bipartite manner—the RHR domain of RelA contacts
the KIX domain of CBP/p300 and the TAD of RelA contacts the
TAZ1 (also known as the CH1) domain of CBP/p300 [20]. The
former interaction requires RelA-phosphorylation at a well-
conserved Ser276 residue. Although both the RHR:KIX and
TAD:TAZ1 interactions contribute to transcriptional activation of
RelA-dependent genes, phosphorylation of Ser276 is considered
critical for the RelA:CBP/p300 interaction [20]. It remains
unclear whether the interaction between the RelA–TAD and the
TAZ1 domain of CBP/p300 can activate transcription of RelA-
target genes independent of RelA(Ser276) phosphorylation or vice
versa. In addition to CBP/p300, RelA also interacts with a
number of other proteins for the transcriptional activation of its
target genes through its TAD, and hence a detailed knowledge of
the TAD:TAZ1 binding is a necessary prelude to any mutations in
the RelA–TAD, which can selectively abrogate RelA:CBP/p300
interaction [16].
As an initial step towards elucidating the role of NF-kB:CBP/
p300 interaction in transcription of NF-kB-regulated genes, we
determined the solution structure of the mouse RelA–TA2 (a
subdomain of TAD) in complex with the TAZ1 domain of mouse
CBP. The structure reveals the high affinity binding of RelA–TA2
through its well-conserved hydrophobic sites (Figure 1B) in a series
of grooves on the TAZ1 surface. The structure enabled us to
design point mutants of RelA, which selectively abrogated the
RelA–TAD:CBP–TAZ1 binding, thereby allowing us to gain
detailed insight into the molecular determinants of the RelA:CBP/
p300 interaction. Using these RelA mutants defective in CBP/
p300 binding, we performed a genome-wide analysis of the genes
influenced by the RelA:CBP/p300 interaction to confirm the
differential role of the two interaction sites on the RelA regulated
transcriptome. We found genes like nfkbia and ptgs2, which were
previously considered independent of RelA:CBP/p300 interaction
[19], were actually dependent on it. The dependence of nfkbia
expression on RelA:CBP/p300 interaction explains how this
interaction regulates the temporal profile of nuclear NF-kB (nNF-
kB) following TNFa stimulation. Furthermore, we revisited the
model of CBP/p300 recruitment by RelA using Chromatin
Immunoprecipitation (ChIP) assay. Our study confirmed that
CBP/p300 is preloaded on the promoter regions of our set of RelA
target genes, thus indicating that RelA:CBP/p300 interaction
might be vital for recruitment of RelA to its target promoter sites.
Results
Mapping of the CBP–TAZ1 Binding Site on RelA–TAD
The RelA–TAD:CBP–TAZ1 interaction was previously
mapped to RelA(477–504) region [20] (Figure 1A). We found
only a weak interaction between this RelA fragment and TAZ1 as
compared to the whole RelA–TAD [RelA(425–549)] and there-
fore scanned the entire TAD for TAZ1 binding using GST pull-
down assays (Figure S1). A RelA construct spanning residues
Lys425–Pro490 (in the TA2 region) emerged as the minimal
fragment with maximal affinity to TAZ1. This fragment (hence-
forth referred to as RelA–TA2) was also optimal for structural
analysis by NMR spectroscopy (Figure S1B,C). This highly acidic
RelA–TA2 fragment is unstructured in its free state, as observed
from the narrow dispersion of peaks in the [15N-1H]–HSQC
spectrum, but exhibits a well-dispersed spectrum indicative of a
folded structure when in complex with TAZ1 (Figure 1C).
Structure of CBP–TAZ1 in the RelA–TA2:CBP–TAZ1
Complex
The structure of the complex between RelA–TA2 (residues
425–490) and CBP–TAZ1 (residues 340–439) was determined
using distance and dihedral angle restraints derived from hetero-
nuclear NMR experiments (see Table 1 for NMR statistics). TAZ1
is a scaffolding domain that interacts with intrinsically disordered
TADs of various transcription factors, which fold upon complex
formation [21–23]. The overall structure of TAZ1 in the complex
(Figure 2) resembles that of TAZ1 in its free state (RMSD 1.6 A˚)
and in complex with other protein targets like HIF-1a (RMSD
1.8 A˚), CITED2 (1.4 A˚), and STAT2 (RMSD 1.3 A˚) [21,23–25].
As observed in our structure, the TAZ1 fold comprises four a-
helices (a1, a2, a3, and a4) arranged in a roughly tetrahedral shape
and is stabilized by three zinc atoms, each of which is bound to
three Cys residues and one His residue. A prominent surface
feature of the TAZ1 domain is a series of interlinked hydrophobic
grooves that bind intrinsically disordered TADs (Figure S2).
Author Summary
The NF-kB family of transcription factors regulate the
expression of numerous genes involved in the immune
response, cell survival, differentiation, and proliferation.
The interaction of the RelA subunit of NF-kB with the
general co-activator protein CBP/p300 is vital for RelA-
dependent gene transcription. Although the recruitment
of RelA to its cognate genomic kB sites for target gene
activation is well-established, the involvement of CBP/p300
in this process remains unclear. Through our structure/
function-based approach we provide the molecular and
functional details of the RelA:CBP/p300 interaction and its
contribution to the regulation of distinct subsets of target
genes. We also show that disruption of this interaction
deregulates the NF-kB pathway by interfering with its
negative feedback loop. Furthermore, our study indicates a
possible reciprocal role for CBP/p300 in the recruitment of
RelA to its target gene promoters.
Structure-Function Role of RelA:CBP/p300 Binding
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Figure 1. The intrinsically disordered RelA transactivation domain folds on the TAZ1 domain of CBP. (A) Schematic of domain
organization of RelA and CBP. The approximate boundaries for CBP were taken from the uniprotkB database (primary accession number P45481).
* denotes the nuclear localization signal (NLS). (B) Sequence alignment of mammalian RelA–TA2 region. The yXXyy motifs and the yyXXyXXy
sequence are marked over the sequence, where y is a hydrophobic residue and X can be any residue. The sequence alignment was done using
Jalview Version 2 software [77]. (C) [15N-1H]-HSQC spectra of 15N labeled free RelA–TA2 (425–490) (upper left panel), 15N labeled RelA–TA2 in complex
with unlabeled TAZ1 (340–349) (upper right panel), 15N labeled free TAZ1 (lower left panel), and 15N labeled TAZ1 in complex with unlabeled RelA–
TA2 (lower right panel). [15N-1H]-HSQC spectra with narrow dispersion in the 1H dimension as observed for the free RelA–TA2 fragment indicate
unstructured protein.
doi:10.1371/journal.pbio.1001647.g001
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Figure 2. NMR structure of the RelA–TA2:CBP–TAZ1 complex. RelA–TA2 is shown in green and TAZ1 in red. The three Zn2+ ligands are
depicted in blue. The ordered region of the RelA fragment (Leu434–Val481) and TAZ1 (Ala345–Asp437) is depicted unless otherwise mentioned. (A)
Twenty superimposed lowest energy NMR structures of RelA–TA2:CBP–TAZ1 complex. (B) Cartoon depiction of the lowest energy model of RelA–
TA2:CBP–TAZ1 complex. (C) Electrostatic potential of solvent accessible surface of TAZ1 in complex with RelA–TA2. The positive potential is shown in
blue and the negative in red. RelA–TA2 is shown as green ribbon with its acidic residues shown as red ball-and-sticks. RelA fragment (Gly430–Met483)
is depicted in this figure.
doi:10.1371/journal.pbio.1001647.g002
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Structure of RelA–TA2 in the RelA–TA2:CBP–TAZ1
Complex
In the RelA–TA2:TAZ1 structure, the N- and C-terminal
regions of the RelA–TA2 fragment used for structural analysis
(Lys425–Thr433 and Ser482–Pro490, respectively) are dynami-
cally disordered, with zero or negative [1H]-15N heteronuclear
NOEs (Figure S3A), and hence are omitted from the structures
shown in Figure 2A,B. Our structure shows that RelA–TA2,
essentially the Leu434–Val481 region, entirely wraps around
TAZ1 in a predominantly extended conformation by docking itself
through its well-conserved bulky hydrophobic residues into the
interlinked hydrophobic grooves of TAZ1 (Figure 2 and Figure
S4A). The C-terminal region (Glu471–Asn477) of RelA–TA2 folds
into one short helix aC that is anchored to the hydrophobic pocket
formed by packing of a1, a2, and a3 helices of TAZ1 (Figure 2B).
Likewise, the N-terminal region (Leu434–Leu439) of RelA–TA2
also forms a short helix aN, which is docked into the shallow
hydrophobic groove formed at the junction of a1 and a4 of TAZ1.
The aN helix is dynamically disordered with only about 30% of
the helical population, as calculated from the magnitude of the C-
alpha and carbonyl secondary chemical shifts [26] (Figure S3B),
and the small value of the [1H]-15N heteronuclear NOE (,0.3–0.5
for the aN residues) confirms that this region is highly flexible on
the nanosecond time scale (Figure S3A). RelA–TA2 also forms two
additional helical turns, Leu449–Leu452 and Leu465–Val468,
which make hydrophobic contacts in the a1–a2–a3 and a1–a3
interfaces of TAZ1, respectively. The hydrophobic interactions are
complemented by electrostatic interactions between the highly
acidic RelA–TA2 region and the strongly electropositive surface of
TAZ1. The region from Asp444–Asp448 in RelA–TA2 is
particularly acidic, with four out of five residues being negatively
charged, and passes through a deep cleft in the TAZ1 surface that
is lined with basic residues (Lys366, Arg368, Arg369, Lys419,
Lys438, Arg439) (Figure 2C). Our structural analysis was further
corroborated by ITC experiments carried out at two different salt
concentrations to study the electrostatic contribution of the
binding event. Increasing the NaCl concentration from 50 to
150 mM weakened RelA–TA2:TAZ1 binding by 4-fold, consis-
tent with a significant electrostatic contribution to binding from
the complementary charges on TAZ1 and the RelA–TA2 region
(Table 2).
RelA–TA2 Anchors on CBP–TAZ1 Through Multiple
Hydrophobic Residues
The structure of the RelA–TA2:TAZ1 complex revealed that
several hydrophobic residues in RelA–TA2 mediate binding
within the exposed hydrophobic grooves of TAZ1. The RelA–
TA2 amino acid residues, which extensively interact with the
hydrophobic pockets of TAZ1, belong to two yXXyy motifs and
a yyXXyXXy sequence (Figure 3A), where y is a bulky
hydrophobic residue (Leu, Val or Phe in RelA–TA2) and X can be
any residue (Figure 1B). The yXXyy motif is a generalization of
the LXXLL motifs that are known to mediate protein–protein
interactions [27]. Furthermore, Val481, Phe443, and the Leu
residues belonging to the aN helix of RelA–TA2 also contribute to
complex formation as observed from the intermolecular NOEs
(Figure S4B).
To investigate the role of the yXXyy motifs, we substituted
alanine for Leu449 and Phe473 of RelA, each of which represents
the first y residue of the motif. Both Leu449 and Phe473 are
deeply buried in the molecular interface and participate in
extensive hydrophobic interactions (Figures 1B and 3A). We also
replaced the third y residue of yyXXyXXy sequence with Ala–
Leu465Ala (Figure 3A, middle panel and Figure S4A). All three
RelA mutants showed diminished to completely abrogated TAZ1
binding in the GST-pulldown assays (Figure 3B) and isothermal
calorimetric (ITC) experiments (Figure S5, Table 2, Figure 3C),
confirming the critical role of hydrophobic interactions in
stabilizing the complex. The Leu449Ala and Leu465Ala substitu-
tions each led to a 7-fold decrease in the TAZ1 binding affinity
(Figure 3C and Table 2). As seen in the structure, the side chain of
Leu465 is fully buried into a deep narrow hydrophobic pocket
formed by Ile353, Leu357, Gln413, Ile414, His417, Trp418,
Cys426, and Val428 of TAZ1 and Val468 of RelA (Figure 3A,
middle panel and Figure S4A). This interaction contributes
significantly to enthalpic stabilization of the complex, since the
Leu465Ala substitution greatly decreases the enthalpic contribu-
tion to TAZ1 binding (Figure 3C). Leu449 binds in a shallower
hydrophobic pocket, and accordingly substitution by alanine
causes far less enthalpic destabilization (Figure 3A, left panel). The
Phe473Ala mutation led to a complete loss of TAZ1 binding. In
the structure, the side chains of Phe473, Leu476, and Leu477 (all
the y residues of this yXXyy motif) are accommodated in the
hydrophobic groove of TAZ1 (Figure 3A, right panel and Figure
S4A). This arrangement is destabilized in the Phe473Ala mutant,
leading to complete loss of TAZ1 binding. We speculate that a
Table 1. NMR and refinement statistics for protein structures.
Statistics RelA(TA2):TAZ1
NMR distance and dihedral constraints
Distance constraints
Total NOE 2,012
Intra-residue 684
Inter-residue
Sequential (|i – j| = 1) 448
Medium-range (2,= |i – j|,= 4) 441
Long-range (|i – j|.= 5) 186
Intermolecular 253
Hydrogen bonds 0
Total dihedral angle restraints
w 110
y 109
Structure statistics
Violations (mean and s.d.)
Distance constraints (A˚) 0.0860.02
Dihedral angle constraints (u) 0.6260.03
Max. dihedral angle violation (u) 0.64
Max. distance constraint violation (A˚) 0.21
Deviations from idealized geometry
Bond lengths (A˚) 0.010360.0007
Bond angles (u) 2.65760.052
Average pairwise r.m.s. deviation** (A˚)
Heavy 1.208
Backbone 0.722
**Pairwise r.m.s. deviation was calculated among 20 refined structures for the
regions (TAZ1): K349–A372, T386–N434; (RelA(TA2): L434–V481.
The Ramachandran plot of the RelA(TA2):TAZ1 structure, 92.0% of the
backbone dihedral angles were in the most favorable region, 7.9% in the
additionally allowed region, 0% in the generously allowed region, and 0% in the
disallowed region.
doi:10.1371/journal.pbio.1001647.t001
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similar effect would be observed for Leu476Ala and Leu477Ala
mutants.
Apart from the above-mentioned residues of RelA–TA2, the
contacts between TAZ1 and the disordered aN helix of RelA–TA2
contribute slightly to formation of the RelA–TA2:TAZ1 complex
(Figure S4B). N-terminal truncation to remove residues Lys425–
His440, thereby eliminating the entire aN helix, decreases the
affinity by only 1.6-fold (Figure 3C and Table 2). Likewise,
deletion of residues Ser486–Pro490 from the disordered C-
terminal end of RelA had no effect on TAZ1 binding (Figure
S1D). However, further truncation to remove Val481–His485
greatly impaired binding by eliminating hydrophobic contacts
between Val481 of RelA(TA2) and the side chains of Leu359,
Leu381, and Pro382 in TAZ1. Replacement of Met483 by alanine
had no effect on binding (Figure 3B), confirming that RelA
residues beyond Val481 do not contribute to the interaction.
In summary, our structure shows that RelA–TA2 spirals
through the exposed hydrophobic pockets of TAZ1 and anchors
itself on TAZ1 at a number of points. As observed from the
mutation studies, disruption of any of these anchoring residues of
RelA–TA2 leads to the destabilization of the entire binding
architecture of the entire complex.
Possible Role of Phosphorylation in RelA–TA2:CBP–TAZ1
Binding
The RelA–TA2 region also contains a well-conserved Ser467
(Ser468 in human RelA), which is a known phosphorylation site.
Depending upon the stimulus, this site can be phosphorylated by
GSK3b, IKKe, or IKKb and plays a critical role in transcriptional
regulation of NF-kB dependent genes [28–31]. Ser467 resides in
the yyXXyXXy sequence of RelA–TA2 (Figure 1B), and in the
complex it is close to the cluster of basic residues at the N-terminus
of helix a1 of TAZ1. Our ITC experiments show that a
phosphomimetic mutant, RelA(Ser467Asp), binds TAZ1 with
about 1.4-fold higher affinity than wild type RelA–TA2 and
exhibits the same dependence on ionic strength, suggesting an
enhanced but still nonspecific electrostatic interaction (Table 2 and
Figure 3C). Thus, the increased negative charge of phosphoserine
would likely enhance TAZ1 binding even further over nonpho-
sphorylated RelA.
Comparative Binding Analysis of RelA–RHR:CBP–KIX and
RelA–TA2:CBP–TAZ1 Interactions
In addition to the RelA–TA2:TAZ1 interaction, the RelA–
RHR interacts with CBP–KIX via p-Ser276–RelA [20]. We
compared the binding of RHR to KIX and TA2 to TAZ1 by
GST-pulldown assay using nuclear extracts (NEs) of wild-type 3T3
cells stimulated with TNFa for 30 min. KIX and TAZ1 were
purified as GST-fusion proteins and used to pull down nuclear-
RelA (nRelA). As seen in Figure 4A, significantly lower amounts of
nRelA were pulled down by GST–KIX compared to GST–TAZ1,
which can be due to either of the two possibilities or both: first, a
lower binding affinity of RelA–RHR:KIX compared to RelA–
TA2:TAZ1 complex, and second, presence of only a small fraction
of p-Ser276–RelA in the total pool of nRelA. In this context, we
compared the binding affinities reported in the literature for KIX
with other target proteins [32,33] and found the reported binding
affinities for KIX complexes typically 10–100-fold lower than
those observed for various TAZ1 complexes [32,33].
Overall, in either possible scenarios the total amount of RelA–
TA2 bound to TAZ1 is significantly higher than that of RelA–
RHR bound KIX, which should be reflected in a subset of RelA-
activated genes that is regulated through RelA–TA2:TAZ1
interaction and is independent of p-Ser276–RelA:KIX binding.
RelA–TA2 Mutants Selectively Abrogate the RelA:TAZ1
Component of the Bipartite RelA:CBP/p300 Interaction
Next, we studied the role of the critical hydrophobic residues of
RelA–TA2 (Leu449, Leu465, and Phe473) on TAZ1 binding in
the context of full-length RelA. We used in vitro purified GST-
tagged TAZ1 to pull down full-length wild-type (wt) or mutant
RelA (Figure 4B) from the NEs of TNFa treated rela2/2 cells (see
Materials and Methods) reconstituted with RelA(wt/mutants). We
found that the RelA mutants, namely RelA(Leu449Ala+-
Phe473Ala) and RelA(Leu449Ala+Phe473Ala+Ser467Ala), were
completely defective in binding to TAZ1 (Figure 4B). As expected,
the Ser276Ala mutation had no effect on TAZ1 binding.
Interestingly, the RelA(Leu449Ala) mutant did not show any
noticeable decrease in binding affinity, contrary to the impaired
TAZ1 binding observed in our in vitro GST pulldown and ITC
experiments. A possible explanation is that in vivo posttranslational
modifications like the phosphorylation of the well-conserved
Ser467 could potentially mitigate the effects of the Leu449
mutation, thus increasing binding affinity of the RelA–TA2 to
TAZ1, as observed by ITC experiments (Figure 3C and Table 2).
Additionally, in the context of full-length RelA, the other domains
of RelA could further influence the RelA–TA2:TAZ1 binding.
The above experiments established the minimal subset of
mutations required in RelA to selectively prevent its interaction
with the TAZ1 domain of CBP. These RelA mutants along with
Table 2. Summary of dissociation constants and thermodynamic parameters obtained from ITC experiments.
RelA Peptides Conc. NaCl (mM) Dissociation Constants (nM) DH (kcal/mol) TDS (kcal/mol)
425–508 wt 50 57.063.2 25.960.1 3.960.1
425–508 (S467D) 50 41.260.3 26.560.1 3.560.1
425–508 wt 150 244.4611.3 27.260.1 1.860.1
441–508 wt 150 386.8633.4 28.360.4 0.560.5
425–508 (L449A) 150 1,604.56194.1 25.460.3 2.560.3
425–508 (L465A) 150 1,706.86434.5 22.460.3 5.560.5
425–508 (F473A) 150 NB* NB* NB*
425–508 (S467D) 150 173.967.2 27.860.1 1.460.1
*NB = No Binding under experimental conditions.
Thermodynamic parameters of binding are mentioned along with standard deviation (s.d.).
doi:10.1371/journal.pbio.1001647.t002
Structure-Function Role of RelA:CBP/p300 Binding
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Figure 3. RelA–TA2 docks itself onto a series of interlinked hydrophobic grooves of TAZ1 through a number of hydrophobic
residues, which serve as anchor points. Disruption of any of the anchor points leads to the destabilization of the whole binding architecture of
Structure-Function Role of RelA:CBP/p300 Binding
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the RelA(Ser276Ala) were further tested for their interaction with
endogenous CBP by coimmunoprecipitation (co-IP). Binding of all
three RelA mutants [RelA(Leu449Ala+Phe473Ala), RelA(-
Leu449Ala+Ser467Ala+Phe473Ala), and RelA(Ser276Ala)] to
endogenous CBP was impaired relative to RelA(wt) (Figure 4C).
However, the disruption of either component of the RelA:CBP
interaction—RHR:KIX or TA2:TAZ1—diminished but could
not completely abrogate the entire RelA:CBP interaction. The
RelA(Leu449Ala+Phe473Ala) and RelA(Ser276Ala) mutants were
equally defective in binding to p300 (Figure 4D), whose TAZ1
domains share high sequence identity with CBP [22].
Role of RelA(Ser467) Phosphorylation in RelA:CBP/p300
Interaction
To further elucidate the role of Ser467 in RelA:CBP/p300
binding, we first studied the RelA(Ser467) phosphorylation
event both spatially and temporally following TNFa stimulation.
As shown in Figure S6A, the amount of p-Ser467–RelA is
negligible in the unstimulated cells. Phosphorylation increases
within 5 min of TNFa stimulation, reaching its maximum at 10
to 15 min followed by gradual dephosphorylation starting at
20 min after stimulation. We confirmed the presence of p-
Ser467–RelA exclusively in the nucleus [34] (Figure 4E). The
timing of RelA nuclear entry coincides with the p-Ser467–RelA
maximum, indicating a possible correlation between the Ser467
phosphorylation event and an enhanced early RelA:CBP/p300
interaction. This correlation holds true only if Ser467 phos-
phorylation contributes towards increasing the affinity. To
confirm this, co-IP experiments with a-CBP and a-p300 using
NEs of RelA(wt) and RelA(Ser467Ala) mutants at three different
time points after TNFa stimulation (Figure 4E) in addition to
unstimulated condition were performed. Interestingly, in the
RelA(wt) reconstituted cells, despite lower amounts of nRelA at
15 min than at 30 min of TNFa treatment, equivalent amounts
of RelA co-immunoprecipitated with CBP/p300. The amount
of nRelA bound to CBP/p300 at 45 min after TNFa
stimulation diminished significantly. The nonlinearity of the
amounts of nRelA co-immunoprecipitated with CBP/p300 with
respect to the nRelA concentration is attributed to the enhanced
binding affinity of p-Ser467–RelA for CBP/p300, as this
nonlinearity was not observed for the identical experiment
performed using RelA(Ser467Ala) mutant reconstituted rela2/2
cells (Figure 4E, Figure S6B).
Despite the role of p-Ser467–RelA in RelA:CBP/p300 binding,
RelA(Leu449Ala+Phe473Ala) mutant [henceforth known as the
RelA(TA2) mutant] was selected for further gene expression
experiments due to two reasons: First, it had the minimal number
of mutations required to impair the RelA–TA2:TAZ1 interaction.
Second, RelA(Ser467) is a key determining factor for various other
processes in the NF-kB pathway [28,35,36], which could further
complicate and lead to misinterpretation of our experimental
observations. Therefore, the RelA(Leu449Ala+Ser467Ala+-
Phe473Ala) mutant was not used further in this study.
RelA–TA2:TAZ1 Drives the Transcription of a Subset of
NF-kB Target Genes Independent of RelA(Ser276)
Phosphorylation
Next we investigated the effect of RelA:CBP/p300 interaction
on the inducible expression profile of NF-kB target genes by qRT-
PCR. Expression of the target genes was tested in the rela2/2 cells
reconstituted with RelA(wt/mutants) following TNFa stimulation.
Fibroblast cells were used because in this cell type the NF-kB-
driven transcription is mainly carried out by the RelA subunit
[16,37]. rela2/2 cells reconstituted with an empty vector were used
as a control, which also ensured that the genes tested were RelA
dependent. The set of nine RelA-dependent genes are well-studied
early TNFa responsive genes (Figure 5A) [16,19,38]. In this gene
set, ptgs2 and nfkbia are NF-kB target genes believed to be
independent of RelA:CBP/p300 interaction [19].
Our qRT-PCR data demonstrated inducible expression for all
of the genes in the chosen set following TNFa stimulation in the
RelA(wt) reconstituted rela2/2 cells. However, the expression of all
the nine genes was significantly diminished in the cells reconsti-
tuted with RelA(TA2) mutant (Figure 5), suggesting that genes like
ptgs2 and nfkbia, which are believed to be independent of
RelA:CBP/p300 interaction, are actually dependent on Re-
lA:CBP/p300 binding through the RelA–TA2:TAZ1 component
(Figure 5A).
On the other hand, for the RelA(Ser276Ala) reconstituted cells,
only seven of the nine genes displayed reduced gene expression.
The relative mRNA levels of the remaining two genes, namely
vcam1 (NM_011693) and ptgs2, were not affected by the
RelA(Ser276Ala) mutation following TNFa stimulation (Figure 5).
In our study, expression of nfkbia, which is believed to be
independent of Ser276 phosphorylation, appeared to be partially
dependent on it. The lower levels of nfkbia mRNA in the
RelA(Ser276Ala) reconstituted cell line following TNFa stimula-
tion as compared to those observed for RelA(wt) reconstituted cells
could possibly be due to the lower expression of RelA(Ser276Ala)
mutant in the cell relative to RelA(wt) and RelA(TA2) mutant
(Figure S7).
Comparative Genome-Wide Expression Analysis Reveals
That a Major Set of RelA Target Genes Is Regulated by
the RelA–TA2:TAZ1 Interaction
To ascertain the effect of the RelA:CBP/p300 interaction on
the RelA-regulated transcriptome, we carried out RNA-seq
analysis of total mRNA isolated from RelA(wt/mutants) reconsti-
tuted cells prior to TNFa stimulation as well as at two different
times points after TNFa stimulation (Figure 5B). The set of genes
activated upon TNFa stimulation was classified into four groups:
Group A contains genes that are dependent on both the
interaction components of the RelA:CBP/p300 complex. Group
B contains those dependent only on the RelA–TA2:TAZ1
interaction. Group C contains genes that are dependent only on
p-Ser276–RelA, and Group D contains TNFa activated genes,
which are RelA regulated but are altogether independent of
the complex. ,2,800 A˚2 of RelA–TA2 surface area are buried upon formation of RelA–TA2:TAZ1 complex. (A) Leu449 (left panel), Leu465 (middle
panel), and Phe473 (right panel) residues of RelA–TA2 (shown as green spheres) buried into each face of the interlinked hydrophobic grooves of
TAZ1. Residues of TAZ1 making contacts with the above mentioned hydrophobic residues of RelA are shown as red sticks. The other hydrophobic
residues of RelA–TA2—namely, Leu452, Val468, Leu476, and Leu477—making vital contacts with TAZ1 are depicted as green sticks. (B) GST-pulldown
experiments performed on the RelA–TA2 mutants binding to TAZ1. RelA fragment (Lys425–Pro490) with N-terminal GST-tag was used as the wild-
type protein. All the mutations were made using this construct as a template. (C) Vertical bar chart of the association constants (left vertical axis, black
bars) and enthalpy change (right vertical axis, grey bars) obtained from the ITC binding isotherms of the RelA–TA2:TAZ1 interaction corresponding to
the respective RelA–TA2 wt and mutants (see Figure S5). The Leu449Ala and Leu465Ala mutants in RelA–TA2 lead to diminished association
constants accompanied with decreased negative enthalpy change. The Phe473Ala mutant showed no binding (NB).
doi:10.1371/journal.pbio.1001647.g003
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RelA:CBP/p300 interaction, or the genes that are activated by
transcription factors other than RelA. The RNA-seq data revealed
that a majority of the RelA:CBP/p300 target genes belong to
Group B (25 genes) followed by Group A (20 genes) and Group C
(six genes). A sizable number of RelA target genes belong to
RelA:CBP/p300 independent Group D (48 genes) (Figure 5B).
Based on these experiments, it is clear that the RelA–TA2:TAZ1
interaction regulates a subset of RelA target genes independent of
p-Ser276–RelA. Thus, the subset of RelA-activated genes depen-
dent on RelA:CBP/p300 interaction is much larger than
previously believed.
The gene expression analysis revealed nfkbia (IkBa) and tnfaip3
(A20), which control the negative feedback loop of the NF-kB
pathway, are dependent on RelA:CBP/p300 interaction. IkBa
essentially is the main NF-kB inhibitor, which strongly controls the
negative feedback and is responsible for the fast turnoff of the NF-
kB response after TNFa treatment in fibroblast cells [39].
Therefore, we asked whether reduced expression of nfkbia due to
defective RelA:CBP/p300 interaction had any effect on the NF-
kB pathway.
RelA:CBP/p300 Interaction Regulates the Temporal
Control of IkBa and nRelA
To study the effect of the RelA:CBP/p300 interaction on nfkbia
expression in detail, we investigated the temporal profile of the
IkBa protein in rela2/2 cells reconstituted with RelA(wt/mutants)
following TNFa stimulation. This study was also performed to
ensure that the RelA mutations did not interfere with the upstream
NF-kB pathway in the cytoplasm or with the DNA binding
property of RelA. nfkbia is a prominent RelA target gene, which
has a robust NF-kB responsive promoter. IkBa is a strong negative
regulator of nuclear NF-kB (nNF-kB) and hence a key determi-
nant of the nNF-kB temporal profile [39]. The canonical NF-kB
pathway stimulated by TNFa has been extensively studied and
focuses on the activation of the IKK-IkB-NF-kB signaling module.
A mathematical model, which accounts for experimentally
observed nNF-kB activity and IkB expression profiles, has been
established [40,41]. This model depends on the abundance and
the transcriptional activation potential of NF-kB (RelA) [42,43],
among other parameters.
We observed that the normalized protein levels of RelA in the
rela2/2 cells reconstituted with RelA-mutants varied relative to
that in RelA(wt)-reconstituted cells (Figure 6A). This prompted us
to simulate the effect of NF-kB abundance on the temporal profile
of nNF-kB activity following TNFa stimulation (Figure 6B) before
studying the transcriptional activation potential of the RelA-
mutants. The simulations show that a decrease in the total NF-kB
concentration leads to sustained nNF-kB activity and lower levels
of IkBa synthesis following TNFa stimulation (Figure 6B).
We next compared the nuclear translocation of RelA and the
temporal profile of IkBa protein following TNFa stimulation in
rela2/2 cells reconstituted with wild-type or mutant RelA. To
detect nNF-kB in NEs, the NF-kB DNA binding activity was
measured by Electrophoretic Mobility Shift Assay (EMSA)
(Figure 6C). nRelA levels were also monitored directly by
immunoblotting (Figure S8). The time of entry of RelA(TA2)
and RelA(Ser276Ala) mutants into the nucleus after TNFa
stimulation is identical to that observed for RelA(wt). However,
a prolonged nuclear residence time is observed for RelA(TA2)
mutant relative to RelA(wt) reconstituted cells (Figure 6C and
Figure S8). We also performed similar time course experiments
using the whole cell extracts (WEs) of the respective cells and
monitored the IkBa protein levels by immunoblot (Figure 6D).
While the time of IkBa degradation and RelA entry into the
nucleus are identical in the RelA(wt), RelA(Ser276Ala) and
RelA(TA2) mutant reconstituted rela2/2 cells (Figure 6C,D), the
temporal profile of IkBa regeneration and the nuclear residence
time of RelA differed significantly (Figure 6C–E). For the
RelA(TA2) mutant reconstituted cells, IkBa regeneration is
delayed and does not reach its initial levels within the time course
of the experiment. The RelA(Ser276Ala) mutant on the other
hand did not show any significant delay in IkBa regeneration,
although the IkBa level was reduced.
In order to address our observed results, we applied the
available mathematical model of NF-kB regulation [40,41]. We
assumed that all parameters other than the RelA protein
abundance and its transcriptional activation potential remained
unchanged in all of the RelA reconstituted rela2/2 cell lines.
Identical IkBa degradation and nuclear translocation of RelA for
the three cell lines validated our assumption (through 30 min after
TNFa stimulation in Figure 6C,D and Figure S8). Further, when
the cell-line-specific RelA concentration estimates were incorpo-
rated into the model, the calculated profile for nNF-kB activity
and IkBa abundance matched the experimental data of the
RelA(Ser276Ala) mutant to a significant extent (Figure 6E, lowest
panel), but did not resemble the observed profiles for the
RelA(TA2) mutant (Figure 6E, middle panel). The root mean
Figure 4. Separating the components of the bipartite RelA:CBP interaction to delineate their individual roles. (A, Upper panel) GST-
pulldown assay using in-vitro purified GST–KIX/GST–TAZ1 to pull down nRelA from NEs of wild-type 3T3 cells stimulated with TNFa for 30 min. EDTA
was used to remove the Zn2+ from TAZ1, thereby disrupting the TAZ1 structure. (Lower panel) Coomassie-stained SDS-PAGE gel showing the inputs
for the GST-tagged proteins. (B) GST-pulldown assay using in vitro purified GST–TAZ1 to pull down nRelA from the NEs of RelA(wt/mutants)
reconstituted rela2/2 cells stimulated with TNFa for 30 min. RelA(Leu449Ala+Phe473Ala) and RelA(Leu449Ala+Phe473Ala+Ser467Ala) mutants have
slower mobility on SDS-PAGE gels due to unknown reasons. The expression level of the RelA(Ser276Ala) mutant in the reconstituted cell line was
lower than that for the RelA(wt) (see Figure S6). Hence, a 3-fold excess of NEs was used for the RelA(Ser276Ala) mutant in this experiment. (C)
Interaction of endogenous CBP with nRelA from the NEs of RelA(wt/mutants) reconstituted rela2/2 cells stimulated with TNFa for 30 min studied by
co-immunoprecipitation assay of CBP/RelA followed by immunoblotting by RelA/CBP. The amount of NEs used for RelA(Ser276Ala) mutants was
three times that of RelA(wt/TA2) mutants due to its lower expression levels. The RelA(Ser276Ala+Leu449Ala+Phe473Ala) mutant, which could
potentially abolish the total RelA:CBP interaction, showed low and inconsistent expression and hence was not used in this study. * denotes IgG heavy
chain. (D) The RelA mutants defective in RelA:CBP interaction also are defective binding to p300. The co-IP experiments for p300 was performed
similarly to those in panel (C) of this figure. (E) RelA phosphorylated at Ser467 has higher CBP/p300 binding potential than the nonphosphorylated
form. The immunoprecipitation assay was performed with a-RelA on CE (left column panels) and NE (right column panels) of rela2/2 cells
reconstituted with RelA(wt) or RelA(Ser467Ala) mutant at three different time intervals after being stimulated with TNFa (5 ng/ml) in addition to the
unstimulated cells. Co-immunoprecipitation assays were performed with a-CBP and a-p300 on NE in exactly the same manner as for the IP
experiments above. The recruitment of nRelA by CBP/p300 is similar at 15 min relative to 30 min but diminishes at 45 min after TNFa stimulation
despite the concentration of total RelA in the nucleus being significantly lower at 15 min after stimulation. Identical co-IP experiments with the
RelA(Ser467Ala) mutant shows a direct proportionality in CBP/p300 binding with the concentrations of total nRelA at the different time points after
stimulation. This indicates that the exclusively nuclear p-Ser467–RelA whose concentration peaks at about 10 to 15 min post-TNFa stimulation
possesses a higher binding affinity for CBP/p300 compared to the nonphosphorylated form.
doi:10.1371/journal.pbio.1001647.g004
Structure-Function Role of RelA:CBP/p300 Binding
PLOS Biology | www.plosbiology.org 10 September 2013 | Volume 11 | Issue 9 | e1001647
Structure-Function Role of RelA:CBP/p300 Binding
PLOS Biology | www.plosbiology.org 11 September 2013 | Volume 11 | Issue 9 | e1001647
square deviation (RMSD) was used as a measure of agreement
between calculated and the observed data. The results suggest that
the observed partial expression of nfkbia in RelA(Ser276Ala)
mutant reconstituted cells in our qRT-PCR data (Figure 5) was to
a great extent due to lower expression of this RelA mutant in the
cell line used here.
For the RelA(TA2) mutant, we investigated whether agreement
between the experimentally observed and calculated data could be
obtained by reducing the NF-kB-dependent IkBa mRNA
production rate (kmRNA) parameter to 25%, 12.5%, or 6.25% of
its value for RelA(wt) (Figure 6F). We found that the lowest kmRNA
of 6.25% of RelA(wt) produced the best superimposition of the
calculated and experimentally determined temporal profiles of the
nNF-kB activity and IkBa regeneration as determined by the
RMSD score (Figure 6F, top panel). It should be noted that the
kmRNA is directly proportional to the transcriptional activation
potential of nNF-kB. Our study suggests that the Leu449Ala and
Phe473Ala mutations in RelA lower the transcriptional activation
of NF-kB by impairing the RelA–TA2:TAZ1 component of
RelA:CBP/p300 interaction.
From the above results we conclude that while nfkbia is
dependent on RelA–TA2:TAZ1 interaction, it is independent of
RelA–RHR:KIX interaction. Thus, our data show that disrupting
the RelA–TA2:TAZ1 component of the RelA:CBP/p300 inter-
action disturbs the temporal profile of the nuclear activity of RelA
by interfering with the negative feedback loop of the NF-kB
pathway. This could further deregulate the expression of the
subset of NF-kB-dependent genes, which are independent of the
overall RelA:CBP/p300 interaction.
RelA:CBP/p300 Interaction at the RelA Target Promoters
To further understand the nature of RelA:CBP/p300 interac-
tion on the chromatin, ChIP-qPCR assay was performed to
analyze the chromatin at six RelA target genes in unstimulated
and TNFa-stimulated RelA(wt/mutants) reconstituted rela2/2
cells. We examined the chromatin for RelA occupancy on its
target promoter set (Figures 7A and S9). As expected, we found
that RelA(wt) was recruited to the promoters of all the six genes
(although to a varied extent) at 30 min after TNFa treatment. This
enrichment of RelA(wt) was diminished at 60 min after stimulation
in congruence with its nuclear exit. The recruitment of RelA(TA2)
and RelA(Ser276Ala) mutants to the promoter sites of highly
expressed tnfaip3, nfkbia, and ptgs2 was significantly reduced at
30 min following TNFa treatment compared to RelA(wt), while
for the mutants there was no significant RelA signal detected on
the promoters with low mRNA expression levels (cxcl2, csf2, and
tnf). In agreement with the prolonged nuclear retention of
RelA(TA2) mutant due to a defective negative feedback loop,
reduced amounts of the RelA(TA2) mutant remained bound to the
tnfaip3, nfkbia, and ptgs2 promoters even at 60 min after
stimulation. As indicated earlier, expression of tnfaip3 and nfkbia
were reduced but not completely eliminated. Therefore, the
mRNA levels of the RelA target genes correlate well with the
amounts of RelA recruited to their respective promoters. These
results clearly indicate defects in promoter recruitment of RelA
mutants despite their uncompromised DNA binding potential
(Figure 6C). This led us to hypothesize that CBP/p300 might be
responsible for recruitment of RelA to its target gene promoters. If
our hypothesis were true, then CBP/p300 should be constitutively
loaded on the promoters and there should exist a direct correlation
between the amounts of CBP/p300 present on the promoters to
that of RelA recruited upon stimulation. To test our hypothesis,
the chromatins were analyzed for CBP/p300 enrichment for our
promoter set. The results show CBP/p300 enriched on all of the
promoters to a varied extent, with no significant change upon
TNFa stimulation (Figures 7B and S9). A comparison of CBP/
p300 and RelA signals in this assay revealed a direct correlation
between enrichment of RelA upon stimulation with that of CBP/
p300 (Figure 7C). Similar RelA recruitment was observed for
RelA(wt), RelA(TA2), and RelA(Ser276Ala) mutants on RelA
target promoters independent of RelA:CBP/p300 interaction
(Figure S10).
Since acetylation of histone-3 (H3) at Lys27 by CBP/p300 is a
characteristic of active genes [44], we further examined the levels
of H3 occupancy and compared them with that of acetylated
histone H3 at Lys 27 (H3K27ac). We expected to observe
increased H3K27ac signals on the promoters only after TNFa
treatment as a mark of activated promoters as compared to those
in unstimulated cells. To our surprise we found H3K27ac enriched
in the unstimulated promoters, whose levels remained constant
even after TNFa stimulation. Additionally, the H3K27ac levels
were directly proportional to the amount of CBP/p300 present on
the specific promoters (Figure 7C). This suggests that CBP/p300
bound to promoters of RelA targets is poised for transcription
initiation. Upon nuclear entry RelA is recruited to its respective
promoter targets by CBP/p300, which is preloaded on these sites,
leading to transcription activation.
Upon TNFa stimulation in RelA(TA2) or RelA(Ser276Ala)
mutant reconstituted rela2/2 cells, the mRNA expression levels of
the highly expressed genes like tnfaip3 and nfkbia registered only
partial reduction (Figure 5A). This is because of a reduced but
significant amount of RelA recruited to their respective promoters
(Figure 7A). Both the promoters also maintain high levels of CBP/
p300, thereby leading to recruitment of the RelA(TA2) and
RelA(Ser276Ala) mutants, which possess reduced but significant
CBP/p300 binding affinity (Figure 4C,D). This further proves that
the RelA-dependent gene expression is regulated by the total
amount of RelA recruited on the promoter by CBP/p300.
Figure 5. A subset of RelA:CBP/p300 dependent genes is independent of RelA(Ser276) phosphorylation. (A) Total RNA was isolated and
purified from unstimulated cells at 30, 60, and 120 min of TNFa stimulation and prepared for analysis by RT-PCR. GAPDH was used as a reference and
the 0 min time point for each cell line was used as the calibrator. The respective protein products of the genes (with names other than the gene
name) are in parentheses. The rela2/2 cell line reconstituted with empty vector was included to ensure that RelA regulates the genes under study.
The genes with their respective gene accession numbers (mouse) are as follows: csf2 (NM_009969), cxcl2 (NM_009140), icam1 (NM_010493), nfkbia
(NM_010907), ptgs2 (NM_011198), tnf (NM_013693), tnfaip3 variant 1 (NM_009397), tnfaip3 variant 2 (NM_001166402), tnfsf9 (NM_009404), and
vcam1 (NM_011693). Note that tnfaip3 has two variants. (B) The RelA–TA2:TAZ1 interaction activates a set of RelA target genes independent of p-
Ser276RelA. The expression phenotype was determined for 99 genes that undergo at least 2-fold activation at 1 h of TNFa stimulation as compared
to unstimulated RelA(wt) reconstituted rela2/2 cells. These TNFa-activated genes were grouped into four groups, A–D, based on the observed
expression defect (with 95% confidence) with respect to RelA(wt), in the two distinct RelA:CBP/p300 interaction defective mutant cells (see main text).
The gene list was sorted according to the differences between the RelA(wt) and RelA(TA2) mutant reconstituted cells at 1 h of TNFa treatment. The
genes that switch to other groups upon relaxation of the confidence limit to 67% are labeled with their prospective group names. The genes that
were tested by qPCR are marked with a blue asterisk. vcam1 did not satisfy the stringent criteria of at least 2-fold activation at 1 h of TNFa treatment
and hence could not enter the list.
doi:10.1371/journal.pbio.1001647.g005
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Overall our study indirectly shows that CBP/p300, which marks
the promoter/enhancers of genes, also aids in recruiting RelA to
the promoters of its target genes.
Discussion
In this study, we have provided the structural basis and the
functional role of the RelA:CBP/p300 interaction in RelA-driven
transcription. In the RelA–TA2:TAZ1 structure, the RelA–TA2
region binds within a series of interlinked hydrophobic grooves
that spiral almost entirely around the globular TAZ1 domain. Due
to the intrinsically disordered nature of the RelA–TA2 region,
binding of an elongated ,50 amino acid region to TAZ1 in a
relatively extended configuration can be accomplished without the
energetic cost that would be incurred if unfolding of preexisting
globular structure was required. The interaction is mediated
primarily by hydrophobic residues interspersed with acidic
residues located in the RelA–TA2 region, which dock in the
hydrophobic pockets in the surface of TAZ1. While RelA becomes
more ordered upon interaction with TAZ1, only limited, highly
localized secondary structure is formed. Contacts between the N-
terminal part of the RelA–TA2 and TAZ1 are dynamic,
contributing little to binding affinity, and are an example of what
is frequently termed a ‘‘fuzzy’’ interaction [45]. The hydrophobic
contacts are complemented by electrostatic interactions involving
the many acidic residues in the RelA–TA2 region. Disruption of
any of the hydrophobic contacts leads to a significant decrease in
binding affinity toward TAZ1. This is due to the destabilization of
the ordered RelA–TA2 structure held primarily by the exposed
hydrophobic grooves of TAZ1. Upon disruption of any of the
anchor points, RelA–TA2 in absence of any highly stabilized
secondary structural elements regains its highly dynamic unstruc-
tured high-energy state. This leads to destabilization of the
complex and a decrease in TAZ1 binding affinity. Disruption of
the hydrophobic anchors of RelA–TA2 can also destabilize the
hydrophobic core of TAZ1, which is otherwise stabilized to a
significant extent on complex formation with RelA–TA2 (Figure
S11). This interlinked core of TAZ1 holds the entire RelA–TA2
region in the complex as seen through the contacts of the core
elements with the anchoring residues of RelA–TA2.
The mode of binding of the TAZ1 domain to RelA–TA2 is
closely analogous to its interactions with the transactivation
domains of the HIF-1a, CITED2, and STAT2 proteins [21–
24,46]. In particular, RelA binds in the same hydrophobic grooves
as the HIF-1a C-terminal activation domain but in the reverse
orientation [21], despite the fact that the two proteins share no
common sequence motifs and do not interact with TAZ1 through
common secondary structures. A salient property of TAZ1 is its
ability to interact with long, negatively charged 40–50 residue
regions of intrinsically disordered proteins that dock in the narrow
hydrophobic grooves in its surface. This interaction is further
enhanced by the phosphorylation of Ser467, thereby adding
another layer of regulation for a subset of early response target
genes of RelA following TNFa stimulation. Similar phosphoryla-
tion events are observed in other transcription factors, which
influence their interaction with CBP/p300 [47,48].
To date, inducible phosphorylation of Ser276 is considered to
be the decisive factor for the recruitment of CBP/p300 by RelA
for the transcriptional activation of RelA-dependent genes [19,20].
Earlier studies have shown that in the absence of Ser276
phosphorylation, histone deacetylases (HDACs) could remain
bound to nNF-kB and lead to the repression of NF-kB-dependent
genes [19,49]. Upon phosphorylation at Ser276, RelA readily
recruits CBP/p300, which in turn acetylates RelA at Lys310,
which is further required for the transcription of a subset of RelA-
dependent genes [50,51]. Our experiments show that a major
subset of TNFa-inducible genes is dependent on the RelA–
TA2:TAZ1 interaction. Importantly, a significant number of these
genes (Figure 5B, Group B genes) are activated independently of
Ser276 phosphorylation. For these genes the requirement of p-
Ser276–RelA could be compensated by a synergy between
multiple protein factors (including transcription factors) and RelA.
A similar mechanism was previously observed for cxcl2 and nfkbia
transcription, where the requirement for RelA:TRAP-80 interac-
tion was waived for the expression of these genes through the
recruitment of secondary transcription factors [16]. Similarly, for
tnfaip3 transcription, the constitutive transcription factor Sp1 plays
an important role in synergy with RelA [52]. Moreover, the
location of Ser276 in the DD of RelA could potentially influence
the selectivity of its dimer formation with other NF-kB family
members [53]. Additionally, the proximity of Ser276 to DNA
binding residues of RelA could further impact the kB site
selectivity [54], thereby leading to differential gene expression
and/or compensating for the RelA–RHR:KIX interaction.
In this study, for the first time we show that the negative
feedback loop is directly controlled by RelA:CBP/p300 interaction
through the expression of nfkbia. Similarly, A20 protein (tnfaip3
gene product), another regulator of the negative feedback loop of
the NF-kB pathway, is also directly controlled by RelA:CBP/p300
interaction. The impaired negative feedback loop can impact the
expression profile of TNFa-induced genes. The longer residence
time of RelA in the nucleus can prolong the activation of the genes
that are independent of RelA:CBP/p300 interaction.
RelA is believed to recruit co-activator CBP/p300 to the gene
promoters for transcription activation of its target genes. On the
other hand, recent ChIP-seq and ChIP-chip studies have
Figure 6. Impaired RelA–TA2:CBP–TAZ1 interaction disrupts the negative feedback loop of the NF-kB pathway. (A) Expression of RelA
mutants with respect to RelA(wt) in the RelA reconstituted rela2/2 cell lines. The protein expression levels of RelA(Ser276Ala) mutant was about three
times lower than that for RelA(wt). For the quantitative estimation, the RelA to Actin signal ratio for each cell line was normalized with that for the
RelA(wt) reconstituted rela2/2 cells (lower panel). (B) Model predictions for NF-kB (top) and total IkBa abundance (bottom) for different RelA
expression levels (26, 1.56, 16, 0.56, and 0.26 relative to RelA(wt) values). In the nNF-kB curves, the peak is normalized to one for the highest level
of nNF-kB activity and to zero for its levels in the resting cells (time = 0 min) for each individual expression level. Similarly, for the IkBa curves, the
amount of IkBa in the resting cell (time = 0 min) is normalized to one and the minimum amount after degradation (basal levels) to zero following
TNFa stimulation. (C) nRelA activity assay in response to TNFa stimulation as measured by EMSA using labeled kB probe and control NF-Y probe in
the above-mentioned cells. The activity due to RelA binding to the kB probe was indicated by supershift of the EMSA band corresponding to the
probe-bound NF-kB detected with anti-RelA antibody. 12 mg of NE was used for EMSA. (D) IkBa degradation and regeneration assay in RelA(wt/
mutants) reconstituted rela2/2 cells following TNFa stimulation. IkBa protein levels after stimulation were monitored with respect to Actin. (E)
Comparison of experimentally determined (symbols) and model predictions (solid line) based on adjusted RelA levels for NF-kB (left) and total IkBa
abundance (right). Time courses for rela2/2 cells reconstituted with RelA(wt) (top), RelA(TA2) mutant (middle), and RelA(Ser276Ala) (bottom)
stimulated with TNFa are shown. The experimental data were normalized as mentioned in panel (B) of this figure. The RMSD values correspond to the
combined NF-kB and IkB datasets. (F) Comparison of experimentally determined (N) and model predictions (solid line) for NF-kB (left column) and
total IkBa abundance (right column) for different degrees of suppression of IkBa mRNA production for RelA(TA2) mutant reconstituted rela2/2 cells.
doi:10.1371/journal.pbio.1001647.g006
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Figure 7. The RelA:CBP/p300 interaction influences RelA recruitment to its target gene promoters. ChIP was performed to analyze the
chromatin of six TNFa-induced RelA target genes in unstimulated and TNFa (5 ng/ml) stimulated for 30 and 60 min RelA(wt/mutants) reconstituted
rela2/2 cells. Immunoprecipitation using antibodies against RelA, CBP, p300, histone H3, and H3K27ac were performed. The H3K27ac antibody
showed higher signals compared to the total H3 antibody due to differences in their qualities. The results shown are the average of two independent
replicates, with standard deviations shown as error bars. (A) Fold enrichment of RelA on the promoter of six RelA target genes after TNFa treatment
relative to that in unstimulated cells. (B) CBP/p300 enrichment as depicted by the respective %input for six RelA target genes in unstimulated and
TNFa-stimulated RelA(wt/mutants) reconstituted rela2/2 cells. (C) Comparison of RelA, CBP, p300, H3, and H3K27ac ChIP signals in unstimulated
RelA(wt) reconstituted rela2/2 cells for six RelA target genes.
doi:10.1371/journal.pbio.1001647.g007
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established p300 as a mark for the enhancers/promoters of active/
poised genes throughout the genome including those for RelA
target genes [12,13]. However, the mechanism of its recruitment
by RelA to the promoters remains to be established. In this study,
we found that CBP/p300 was constitutively enriched on the RelA
target promoters as against the TNFa-induced recruitment of
RelA to these sites. This points towards a role played by CBP/
p300 in recruitment of RelA to its target promoters. Although we
have tested only a small set of RelA target promoters, our
observation is consistent with the report by Jin et al. [13], where
they could accurately predict the target selection by NF-kB in a
cell-type-specific manner only when experimentally determined
p300 enrichment of promoters was considered along with kB motif
[55,56] along the human genome.
Materials and Methods
Protein Expression and Purification
The GST tagged mouse RelA fragments were expressed in E.
coli [BL21(DE3) cells] and purified by affinity chromatography
using Glutathione sepharose beads (GE Life Sciences). The
purified protein fragments were then dialyzed in the binding
buffer of the respective experiments.
For NMR experiments, the mouse RelA fragments were
expressed as fusion proteins with an N-terminal His6-tag followed
by the 58 amino acid residue B1 domain of streptococcal protein
G (GB1) as per previous reports [57,58]. The protein was
isotopically labeled by growth in M9 minimal media supplemented
with 15N ammonium chloride and 13C-glucose. The fragments
were purified under denaturing conditions on a Ni-NTA (SIGMA)
column followed by dialysis against cleavage buffer [20 mM Tris
(pH 7.5), 200 mM NaCl] at 4uC. The His6–GB1 peptide was
cleaved by thrombin at room temperature for 18 h. The cleaved
RelA peptides were further purified by reverse-phase HPLC
(RPHPLC) using a C18 column on A¨KTA purifier system. The
purified peptides were lyophilized immediately. For NMR and
ITC experiments, the TAZ1 domain (residues 340–439 of mouse
CBP) was expressed and refolded as described previously [24]. For
ITC experiments, the His6-tag was cleaved from the GB1–RelA
peptides by TEV protease (in house purified).
GST-Pulldown Assay
The GST-pulldown assay was carried out in binding buffer
(20 mM Tris pH 7.5, 150 mM NaCl, and 0.5 mM DTT). GST-
RelA fragments (20 mg) were mixed with purified TAZ1 (10 mg)
and 20 ml of a 50% slurry of washed glutathione sepharose beads
and incubated at 4uC for 30 min in a rotator. The beads were then
washed 5 times with 500 mL of binding buffer containing 0.3%
TritonX-100, followed by elution and analysis by 15% SDS-
PAGE.
Isothermal Titration Calorimetry (ITC)
ITC experiments were performed at 25uC using a MicroCal
Omega VP-ITC instrument. For ITC experiments, GB1-tagged
RelA-TA2 fragments were used. The proteins were dialyzed
overnight in the ITC buffer [20 mM Tris (pH 8.0), 50 mM or
150 mM NaCl and 1 mM DTT]. The protein concentrations
were in the range of 10 to 18 mM of RelA–TA2 peptide in the cell
and 169 to 185 mM TAZ1 in the syringe. Protein concentrations
were determined by absorbance at 280 nm. The GB1-tag was
used for accurate concentration determination of the RelA–TA2
peptides, which have a low extinction coefficient. The GB1-tag did
not interact with TAZ1. A typical ITC experiment consisted of a
total of 25 injections, using 5–6 ml of TAZ1 for the first injection
followed by 24 injections of 11–12 ml of TAZ1 into the cell
containing either blank or RelA peptide. Data were analyzed using
a single-binding site model in the MicroCal Origin Software. The
stoichiometry of binding ranged from 0.9 to 1.2. Errors for the Kd
values were estimated from duplicate measurements. All the
buffers used were made using water purged with nitrogen.
NMR Spectroscopy and Structure Calculations
NMR experiments were carried out at 25uC on Bruker
DRX600 MHz and Avance 900 MHz spectrometers. The typical
protein concentration for NMR experiments was 0.7–1.2 mM. All
spectra were referenced to external DSS. Refolded TAZ1 and
RelA fragments were mixed to form the complex followed by
overnight dialysis in NMR buffer (20 mM Tris pH 6.5, 40 mM
NaCl, and 2 mM DTT). We added 5% D2O to the sample prior
to NMR experiments. NMR data were processed using NMRPipe
[59] and analyzed using CARA [60]. Backbone and side-chain
resonances were assigned using standard triple resonance exper-
iments [61]. Distance restraints were obtained from 3D 15N-edited
NOESY-HSQC (tm = 100 ms) and
13C-edited NOESY-HSQC
(tm = 100 ms) spectra. Intermolecular NOEs were derived from
12C-filtered-13C-edited NOESY-HSQC (tm = 200 ms) [62] exper-
iments. Unambiguous intermolecular NOES were assigned
manually and were used in the initial structure calculations, which
were performed using CYANA [63] with CANDID [64].
Chemical shift-based torsion angles were obtained using TALOS+
[65]. Distance and torsion angle restraints were imposed to ensure
tetrahedral geometry for the zinc atoms of TAZ1 [25]. A total of
200 structures were generated in CYANA and were further
refined by restrained molecular dynamics simulated annealing
using the AMBER 10 software package [66,67].
These structures were subjected to 2,000 steps of energy
minimization, followed by 20 ps of simulated annealing in vacuum
and another 20 ps of simulated annealing using a generalized Born
solvent model [68] and finally 2,000 steps of energy minimization.
During the simulated annealing, the system was heated to 1,000 K
for the first 2 ps, followed by 4 ps at constant temperature, and
final cooling to 0 K for the remaining 14 ps. Force constants were
30 kcal mol21 A˚22 for NOE restraints and 100 kcal mol21 rad22
for dihedral angle restraints. The 20 lowest energy structures were
analyzed using PROCHECK-NMR [69].
Cell Culture and Reagents
Immortalized rela2/2 fibroblast cells [70] were reconstituted
with retroviral vectors pBABE-puro with mouse RelA(wt/mutants)
inserted or with empty vector controls. A final concentration of
5 ng/ml TNFa (Roche Diagnostics) was used for stimulation.
Antibodies used for IB and IP in this study were from Santa Cruz:
anti-RelA (sc-372g), anti-IkBa (sc-371), anti-CBP (sc-369), anti-
Actin (sc-1615) and anti-USF2 (sc-861), anti-a-Tubulin (sc-5286),
anti-p300 (sc-584 and sc-585), and Cell-Signaling Technology: p-
Ser468-RelA (#3039). cOmplete, EDTA-free Protease Inhibitor
cocktail was from Roche Diagnostics. Protein G-beads were from
GE Life Sciences.
Preparation of Cytoplasmic, Nuclear, and WE
For the NE, 3T3 cells were cultured in 10 cm3 plates and
harvested using PBS buffer. Cell pellets were prepared by 5 min
centrifugation at 500 g at 4uC and then resuspended in CE buffer
(0.32 M Sucrose, 10 mM Tris HCl pH 8.0, 3 mM CaCl2, 2 mM
MgOAc, 0.5% NP-40, 1 mM DTT, 0.5 mM PMSF) followed by
centrifugation at 500 g for 5 min at 4uC. The supernatant (CE)
was flash frozen and stored at 280uC. The nuclear pellet was
washed twice with CE buffer without NP-40 followed by
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centrifugation as above. The washed pellet was resuspended in
hypotonic buffer [20 mM HEPES (pH 7.9), 1.5 mM MgCl2,
20 mM KCl, 25% glycerol, 0.5 mM DTT, 0.5 mM PMSF]
followed by gradual addition of high salt buffer [20 mM HEPES
(pH 7.9), 1.5 mM MgCl2, 800 mM KCl, 25% glycerol, 1% NP-
40, 0.5 mM DTT, 0.5 mM PMSF, and 16 complete EDTA-free
protease inhibitor]. The samples were incubated with mild
agitation for 45 min at 4uC followed by centrifugation at
12,000 g at 4uC for 15 min. The supernatant was collected as
NE and was further subjected to quantification.
For WE, the cells were harvested as above followed by addition
of RIPA lysis buffer containing protease inhibitor cocktail. The
samples were centrifuged at 12,000 g at 4uC. The supernatant was
collected as the WE. All of the buffers contained phosphatase
inhibitor cocktail.
Immunoblotting and Co-Immunoprecipitation
For immunoblotting, WEs and NEs were resolved on SDS-
PAGE and immunoblotted with respective antibodies. For co-
immunoprecipitation (co-IP) assay, NEs were incubated with anti-
RelA or anti-CBP antibodies for 1 h followed by addition of
prewashed protein-G beads and incubation for 4 h. The beads
were then washed thoroughly and resolved on SDS-PAGE and
immunoblotted with anti-RelA and anti-CBP antibodies. For
quantitative analysis of the immunoblots, the loading controls were
analyzed from the same gel as for the protein monitored.
Gene Expression Analysis
RNA was extracted and purified as per the manufacturer’s
protocol using the RNeasy kit (QIAGEN). We reverse transcribed
1 mg of the quantified RNA using superscript II RT system
(Invitrogen) and poly-dT primers. cDNA fragments generated
were analyzed by qPCR using the KAPA system and Realplex
thermocycler (EPPENDORF). PCR amplification conditions were
95uC (4 min) and 40 cycles of 95uC (15 s), 56uC (30 s), and 72uC
(30 s). Primer pairs used were from previous studies [38,71] and
were tested by melt-curve analysis. D(DCt) method was used for
data analysis with gapdh as normalization control to derive fold
induction over basal levels. For each set of time-course experiment
(0 min, 10 min, 60 min, and 120 min) RNA was collected from
empty vector, RelA(wt), RelA(TA2), RelA(Ser276Ala) mutant
reconstituted rela2/2 cells stimulated with 5 ng/ml TNFa. For
qRT-PCR experiments, the data were collected for three set of
biological replicates.
Next generation sequencing was performed at the UCSD
Biogem core facility. Reads were obtained from Illumina HiSeq
2000 sequencing system. Sequencing experiments were performed
on the total mRNA extract from RelA(wt), RelA(TA2), and
RelA(Ser276Ala) reconstituted rela2/2 cells at two different time
points after TNFa (5 ng/ml) treatment in addition to unstimulated
cells. RNA-seq was performed on nine different experimental
conditions in total. Two independent replicates were used for each
experimental condition. Reads were mapped to the mm10 mouse
genome using TopHat [72], and the transcriptome assembly was
generated using Cufflinks [73] followed by detection of differen-
tially expressed genes using Cuffdiff.
Computational Simulation
The ordinary differential equation (ODE)-based model for
NF-kB regulation [40] was adapted (Table S1) by increasing
IkB mRNA degradation rates by a factor of 1.8 in line with
recent measurements [74] and replacing the terms describing
transcription-factor-dependent mRNA production for IkBa and
IkBe by those used in [41] (Model 3, additive Pol II
recruitment). Model simulations were carried out with the
‘‘Stiffness Switching’’ method of the NDSolve function in the
package Mathematica 8 (Wolfram Research, Champagne, IL)
using a numerically defined IKK activity induced by exposure
to TNFa Table S2 [40].
ChIP Experiments
Samples for ChIP experiments were prepared using Simple-
ChIP Plus Enzymatic chromatin IP kit (Cell Signaling Technology
#9005) according to the manufacturer’s protocol with some
modifications. Primer pairs used were from previous studies
[38,71,75] and were tested by melt-curve analysis. ChIP exper-
iments were performed with anti-H3 (Cell Signaling #4620), anti-
acetyl H3K27 (Cell Signaling #8173), anti-RNA Pol II (Santa
Cruz sc-900), anti-p300 (Santa Cruz sc-585), anti-CBP (Santa
Cruz sc-369), anti-RelA (Santa Cruz sc-372), and anti-IgG (Cell
Signaling #2729)
Accession Numbers
Coordinates and structural restraints for the RelA–TA2:CBP–
TAZ1 complex have been deposited in the Protein Data Bank
under the accession number 2LWW. The chemical shifts have
been deposited in the BioMagResBank, accession number 18650.
The RNA-seq data discussed in this publication have been
deposited in NCBI’s Gene Expression omnibus [76] and are
accessible through GEO Series accession number GSE46213.
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE46213).
Supporting Information
Figure S1 Optimization of RelA–TAD fragment in RelA–
TAD:TAZ1 complex for structural analysis. (A) Schematic of
GST-tagged RelA–TAD constructs. All constructs were overex-
pressed and purified for the GST-pulldown assays. Construct T11
(marked with an asterisk) was determined to be the optimal
fragment for CBP–TAZ1 binding. (B) GST-pulldown experiment
for optimization of the N-terminal end of the RelA fragment
binding to TAZ1. (C) GST-pulldown experiment for optimization
of the C-terminal end of the RelA fragment binding to TAZ1. (D)
GST-pulldown experiment for studying the importance of the five
amino acids at the C-terminal end of the RelA fragment binding to
TAZ1. (E) Gel filtration elution profile of CBP–TAZ1 domain,
RelA–TA2 fragment, and RelA–TA2:CBP–TAZ1 complex. The
RelA–TA2 fragment was detected at 215 nm due to lack of tyrosine
and tryptophan residues. RelA–TA2:TAZ1 complex and free
TAZ1 were detected at 280 nm. A slight excess of TAZ1 was used
for the complex formation as can be seen in the elution profile of the
complex. (F) Gel filtration elution characteristics of CBP–TAZ1
domain, RelA–TA2 fragment, and RelA–TA2:CBP–TAZ1 com-
plex. The observed molecular weight of RelA–TA2 fragment is
about 3 times that of its calculated molecular weight, which further
confirms the unstructured nature of RelA–TA2 concluded from its
[15N-1H]-HSQC spectra in Figure 1C. Zn2+-bound well-folded
TAZ1 elution profile corresponds to that of a lower calculated
molecular weight protein.
(TIF)
Figure S2 TAZ1 binds to RelA–TA2 through a series of
interlinked hydrophobic grooves. (A) Cartoon representation
of the hydrophobic core of TAZ1. The critical amino acid residues
of the core are shown as pink sticks. These core residues pack the a1,
a2, and a3 helices of TAZ1. (B) Surface representation of TAZ1 (in
the RelA–TA2:TAZ1 complex). The hydrophobic core residues are
colored in pink, and additional hydrophobic residues, which
contribute to each of the grooves, are shown in blue. The three
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hydrophobic groves are interlinked with each other through the
hydrophobic residues of the core (pink). Figure S2A and the left
panel in Figure S2B are represented in the same orientation.
(TIF)
Figure S3 The aN helix of RelA–TA2 in the RelA–
TA2:TAZ1 complex is dynamically disordered. (A) Histo-
grams of [1H]-15N heteronuclear NOE values for 15N-labeled
RelA–TA2 in complex with unlabeled TAZ1 (top panel) and 15N-
labeled TAZ1 in complex with unlabeled RelA–TA2 (bottom
panel). The secondary structural elements are represented
schematically above the corresponding plots. Higher values of
NOEs correspond to more rigid structure. (B) Chemical shift
deviation (CSD) of Ca (top panel) and C9 (bottom panel) for
RelA–TA2 in the complex from that of their sequence-corrected
random coil chemical shifts. The percentage of the helix
population for the RelA–TA2 region in the complex was estimated
from the CSDs of Ca and C9 chemical shifts averaged from
Leu434–Leu439 for the aN and from Ser471–Leu477 for the aC
helix. The secondary chemical shift for a fully formed a-helix is
2.8 ppm and 2.1 ppm for Ca and C9, respectively [26]. The
estimated helical population from the average CSD for the aN and
aC terminal helix of RelA–TA2 is 32% and 84%, respectively.
(TIF)
Figure S4 RelA–TA2 docks into the grooves formed by the
opposite faces of the hydrophobic core of TAZ1. (A) A
surface representation of TAZ1 in the RelA–TA2:TAZ1 complex.
The hydrophobic core residues of TAZ1 are in pink, and the
additional residues of TAZ1 that contribute towards RelA–TA2
binding are colored blue. RelA–TA2 is shown as grey ribbon with its
anchoring hydrophobic residues depicted as green ball-and-sticks.
For RelA–TA2, only the residues with more than 10 intermolecular
NOEs are depicted as ball-and-sticks. (B) Histograms showing the
number of intermolecular NOEs between RelA–TA2 and TAZ1
observed per residue of RelA–TA2 in the complex. Compared to the
aC helix, the aN helix of RelA–TA2 has fewer intermolecular NOEs
as expected from its dynamic nature (see Figure S3).
(TIF)
Figure S5 ITC binding isotherms for the RelA(TA2) (wt/
mutants) with TAZ1. The TAZ1 binding affinity is completely
abolished in the RelA(TA2) (Phe473Ala) mutant. The RelA–TA2
fragment of Lys425–Arg508 was used for all studies (wt and
mutants) unless otherwise mentioned.
(TIF)
Figure S6 (A) The RelA(Ser467) phosphorylation maximum
coincides with nuclear entry of RelA after TNFa stimulation. (A)
RelA immunoprecipitation assay was used to detect RelA(Ser467)
phosphorylation in WEs of RelA(wt) and RelA(Ser467Ala)
reconstituted rela2/2 cells following stimulation with 5 ng/ml
TNFa for the indicated time interval. 150 mg of WE was used for
IP. (B) RelA(Ser467) phosphorylation enhances the binding affinity
of RelA for CBP/p300. (Top panel) Nuclear translocation assay in
RelA(wt) (black) and RelA(Ser467Ala) (red) mutant reconstituted
rela2/2 cells following stimulation with 5 ng/ml TNFa (data from
Figure 4E). The amount of p-Ser467–RelA (grey) was monitored
by RelA IP of NE at mentioned time intervals after TNFa
treatment. (Bottom panel) The RelA:CBP/p300 interaction at
various time intervals after TNFa stimulation was monitored by
Co-IP experiments using CBP/p300 antibodies for RelA(wt)
(black) and RelA(Ser467Ala) mutant (red) (from Figure 4E). The
binding curve for RelA(wt) is shifted to the left, where the
concentration of p-Ser467–RelA is highest. The RelA(Ser467Ala)
mutant shows a linear change in the aforementioned binding with
respect to the concentration of total nRelA. The lines joining the
data points are only used for the purpose of viewing clarity.
(TIF)
Figure S7 Expression levels of RelA in the RelA
reconstituted rela2/2 cells. RelA protein levels (wt and
mutants) were determined in WEs of the RelA reconstituted
rela2/2 cell lines detected by immunoblotting of RelA. Actin was
used as the loading control.
(TIF)
Figure S8 The nuclear residence time of the RelA(TA2)
mutant is longer than RelA(wt) and RelA(Ser276Ala).
RelA nuclear translocation assay in RelA(wt/mutants) reconsti-
tuted rela2/2 cells following stimulation with 5 ng/ml TNFa.
Upstream stimulatory factor 2 (USF2) was used as the loading
control for the NEs.
(TIF)
Figure S9 CBP/p300 aids recruitment of RelA to its
target promoters. ChIP experiments were performed with
RelA, CBP, p300, H3, H3K27ac, RNA polymerase II, and IgG
antibodies in RelA(wt), RelA(TA2), or RelA(Ser276Ala) reconsti-
tuted rela2/2 cells under unstimulated or stimulated conditions for
30 min or 60 min with TNFa. Results are presented as average
%input values with standard deviations from two independent
chromatin preparations. The respective gene names are men-
tioned on the y-axis of each group of panels.
(TIF)
Figure S10 RelA(TA2) mutant has normal promoter
recruitment for RelA:CBP/p300 interaction-indepen-
dent RelA-regulated genes. (A) Gene expression profile of
fosb and nr4a1 genes. fosb (NM_008036) and nr4a1 (NM_010444)
genes belong to the Group D genes (Figure 5B). Kasper et al. have
shown both nr4a1 and fosb were highly expressed following
forskolin stimulation in cbp2/2 and p3002/2 MEF cells [75], thus
indicating their CBP/p300-independent expression. Here both the
genes showed higher TNFa-induced expression in empty vector
reconstituted rela2/2 cells compared to the RelA(wt/mutant)
reconstituted cells. The level of TNFa-induced expression of nr4a1
and fosb was reduced in the presence of RelA(wt) as well as mutants
to a similar extent. This suggests that the transcription of both the
genes is regulated by RelA but is independent of RelA:CBP/p300
interaction. (B) RelA(wt), RelA(TA2) mutant, and RelA(S276)
mutant are recruited to a similar extent on the promoters of fosb
and nr4a1. ChIP-qPCR experiments were performed as men-
tioned earlier (Figure 7) to study RelA recruitment on the
promoter sites of fosb and nr4a1.
(TIF)
Figure S11 The hydrophobic core of TAZ1 is stabilized
upon binding to RelA–TA2 as seen from the deuterium
exchange experiments of 15N-labeled TAZ1 and 15N-
labeled TAZ1 in complex with unlabeled RelA–TA2. (A,
Top row) 2D [15N–1H]-HSQC spectrum of free TAZ1 in H2O
(left panel), 11 min after addition of D2O (middle panel), and
about 33 min (right panel) after addition of D2O. (Bottom row) 2D
[15N–1H]-HSQC spectrum of TAZ1 in complex with unlabeled
RelA–TA2 in H2O (left panel), 11 min after addition of D2O
(middle panel), and about 21 h (right panel) after addition of D2O.
The time reported here is of the first free induction decay (fid)
recorded after addition of D2O. (B) Cartoon representations of
TAZ1 with amino acid residues observed in the 2D [15N–1H]-
HSQC spectrum post-D2O exchange with higher resistance to
exchange are shown as blue sticks. The residues with higher
resistance toward D2O exchange in TAZ1 (in complex with RelA–
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TA2) belong either to the hydrophobic core (Leu357, Leu391, and
Ile415) or around it (Leu360, Gln355, Val358, Leu359, and
Leu361).
(TIF)
Table S1 Parameters for the ODE-based model for NF-
kB regulation.
(DOC)
Table S2 Changes in IKK activity induced by exposure
to TNFa.
(DOC)
Text S1 Supporting procedures legends, deuterium
exchange of backbone amide protons, and gel filtration.
(DOC)
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